$384 Million is the total value of DAFNA Capital Management LLC's 94 reported holdings in Q1 2022. The portfolio turnover from Q4 2021 to Q1 2022 was 17.2% .
Value | Shares | ↓ Weighting | ||||||
---|---|---|---|---|---|---|---|---|
STXS | STEREOTAXIS INC | $51,028,000 | -39.8% | 13,680,554 | 0.0% | 13.30% | -37.7% | |
XBI | New | SPDR SP BIOTECH ETFetf | $24,223,000 | – | 269,500 | +100.0% | 6.31% | – |
FATE | Buy | FATE THERAPEUTICS INC | $19,421,000 | -10.8% | 500,930 | +34.6% | 5.06% | -7.6% |
BPMC | Buy | BLUEPRINT MEDICINES CORP | $15,732,000 | -29.0% | 246,280 | +19.0% | 4.10% | -26.4% |
ACET | Sell | ADICET BIO INC | $14,296,000 | +11.5% | 715,872 | -2.4% | 3.72% | +15.5% |
IBB | Buy | ISHARES TR NASDAQ BIOTECH INDXetf | $13,356,000 | +114.0% | 102,500 | +150.6% | 3.48% | +121.7% |
XENE | Sell | XENON PHARMACEUTICALS INC | $11,622,000 | -7.6% | 380,163 | -5.6% | 3.03% | -4.3% |
KRTX | Buy | KARUNA THERAPEUTICS INC | $10,403,000 | +9.7% | 82,053 | +13.3% | 2.71% | +13.6% |
DXCM | DEXCOM INC | $9,279,000 | -4.7% | 18,138 | 0.0% | 2.42% | -1.3% | |
BHVN | Buy | BIOHAVEN PHARMACTL HLDG CO L | $9,201,000 | +14.9% | 77,600 | +33.6% | 2.40% | +19.1% |
NBIX | NEUROCRINE BIOSCIENCES INC | $7,843,000 | +10.1% | 83,655 | 0.0% | 2.04% | +14.1% | |
CYTK | Buy | CYTOKINETICS INC | $7,785,000 | +27.4% | 211,495 | +57.7% | 2.03% | +32.0% |
NRIX | Buy | NURIX THERAPEUTICS INC | $7,612,000 | -14.2% | 543,344 | +77.4% | 1.98% | -11.1% |
MORF | MORPHIC HLDG INC | $7,286,000 | -15.3% | 181,467 | 0.0% | 1.90% | -12.2% | |
CSII | CARDIOVASCULAR SYS INC | $6,486,000 | +20.3% | 286,988 | 0.0% | 1.69% | +24.7% | |
SNDX | Buy | SYNDAX PHARMACEUTICALS INC | $6,465,000 | -0.4% | 371,987 | +25.4% | 1.68% | +3.2% |
MRUS | Buy | MERUS N V | $6,213,000 | -13.6% | 234,989 | +3.9% | 1.62% | -10.5% |
SAGE | SAGE THERAPEUTICS INC | $5,968,000 | -22.2% | 180,306 | 0.0% | 1.56% | -19.4% | |
RVMD | Buy | REVOLUTION MEDICINES INC | $5,921,000 | +10.8% | 232,101 | +9.4% | 1.54% | +14.9% |
IDYA | Buy | IDEAYA BIOSCIENCES INC | $5,484,000 | -49.6% | 490,061 | +6.5% | 1.43% | -47.8% |
CBAY | Sell | CYMABAY THERAPEUTICS INC | $5,264,000 | -12.9% | 1,692,569 | -5.3% | 1.37% | -9.7% |
ISEE | Buy | IVERIC BIO INC | $5,023,000 | +8.9% | 298,476 | +8.2% | 1.31% | +12.8% |
NTUS | NATUS MEDICAL INC | $5,010,000 | +10.7% | 190,635 | 0.0% | 1.30% | +14.7% | |
APLS | New | APELLIS PHARMACEUTICALS INC | $4,773,000 | – | 93,935 | +100.0% | 1.24% | – |
ATRC | ATRICURE INC | $4,730,000 | -5.6% | 72,029 | 0.0% | 1.23% | -2.1% | |
RCUS | Buy | ARCUS BIOSCIENCES INC | $4,583,000 | -3.4% | 145,217 | +23.9% | 1.19% | +0.1% |
ALEC | Buy | ALECTOR INC | $4,172,000 | +30.1% | 292,747 | +88.6% | 1.09% | +34.9% |
RADIUS HEALTH INCnote 3.000% 9/0 | $3,891,000 | +0.8% | 4,000,000 | 0.0% | 1.01% | +4.4% | ||
ASND | Buy | ASCENDIS PHARMA A/Ssponsored adr | $3,593,000 | +142.8% | 30,612 | +178.3% | 0.94% | +151.6% |
OTIC | Sell | OTONOMY INC | $3,594,000 | -21.5% | 1,497,514 | -31.9% | 0.94% | -18.7% |
MRTX | New | MIRATI THERAPEUTICS INC | $3,511,000 | – | 42,700 | +100.0% | 0.92% | – |
EWTX | New | EDGEWISE THERAPEUTICS INC | $3,460,000 | – | 356,750 | +100.0% | 0.90% | – |
IPSC | Buy | CENTURY THERAPEUTICS INC | $3,234,000 | +103.7% | 256,892 | +156.5% | 0.84% | +111.3% |
ARAY | ACCURAY INC | $3,117,000 | -30.6% | 941,800 | 0.0% | 0.81% | -28.1% | |
Buy | PARDES BIOSCIENCES INC | $3,041,000 | -20.4% | 421,157 | +80.4% | 0.79% | -17.6% | |
Buy | FIELD TRIP HEALTH LTD | $2,936,000 | +249.9% | 2,191,308 | +542.8% | 0.76% | +262.6% | |
ITOS | Buy | ITEOS THERAPEUTICS INC | $2,874,000 | +14.1% | 89,298 | +65.1% | 0.75% | +18.3% |
KALV | KALVISTA PHARMACEUTICALS INC | $2,810,000 | +11.4% | 190,663 | 0.0% | 0.73% | +15.5% | |
RIGL | Buy | RIGEL PHARMACEUTICALS INC | $2,679,000 | +15.0% | 896,100 | +1.9% | 0.70% | +19.1% |
GLPG | GALAPAGOS NVspon adr | $2,647,000 | +12.5% | 42,675 | 0.0% | 0.69% | +16.6% | |
AXGN | AXOGEN INC | $2,637,000 | -15.3% | 332,103 | 0.0% | 0.69% | -12.3% | |
AERI | AERIE PHARMACEUTICALS INC | $2,630,000 | +29.6% | 289,040 | 0.0% | 0.68% | +34.3% | |
AFMD | AFFIMED N V | $2,497,000 | -20.8% | 571,282 | 0.0% | 0.65% | -17.9% | |
FSTX | F-STAR THERAPEUTICS INC | $2,463,000 | -29.3% | 693,785 | 0.0% | 0.64% | -26.7% | |
BCYC | New | BICYCLE THERAPEUTICS PLCsponsored ads | $2,334,000 | – | 53,200 | +100.0% | 0.61% | – |
ATHA | ATHIRA PHARMA INC | $2,173,000 | +3.6% | 160,983 | 0.0% | 0.57% | +7.2% | |
AUTL | New | AUTOLUS THERAPEUTICS PLCspon ads | $2,069,000 | – | 496,150 | +100.0% | 0.54% | – |
SURF | Buy | SURFACE ONCOLOGY INC | $1,999,000 | +32.7% | 680,000 | +115.9% | 0.52% | +37.5% |
KURA | Buy | KURA ONCOLOGY INC | $1,822,000 | +17.4% | 113,329 | +2.3% | 0.48% | +21.8% |
New | DICE THERAPEUTICS INC | $1,798,000 | – | 94,000 | +100.0% | 0.47% | – | |
BWAY | BRAINSWAY LTDsponsored ads | $1,746,000 | +13.4% | 200,000 | 0.0% | 0.46% | +17.6% | |
BMEA | Buy | BIOMEA FUSION INC | $1,712,000 | -26.8% | 383,923 | +22.3% | 0.45% | -24.1% |
RDUS | RADIUS HEALTH INC | $1,695,000 | +27.6% | 191,978 | 0.0% | 0.44% | +32.3% | |
MGNX | Buy | MACROGENICS INC | $1,692,000 | +17.1% | 192,000 | +113.3% | 0.44% | +21.5% |
COGT | COGENT BIOSCIENCES INC | $1,674,000 | -12.7% | 223,554 | 0.0% | 0.44% | -9.5% | |
KNTE | Buy | KINNATE BIOPHARMA INC | $1,668,000 | -11.6% | 148,151 | +39.2% | 0.44% | -8.2% |
RGLS | REGULUS THERAPEUTICS INC | $1,656,000 | -5.4% | 5,555,555 | 0.0% | 0.43% | -1.8% | |
NGM | Buy | NGM BIOPHARMACEUTICALS INC | $1,642,000 | +15.2% | 107,653 | +33.8% | 0.43% | +19.6% |
IMCR | New | IMMUNOCORE HOLDINGS PLCads | $1,611,000 | – | 53,878 | +100.0% | 0.42% | – |
TPTX | Buy | TURNING POINT THERAPEUTICS I | $1,596,000 | -28.0% | 59,452 | +28.0% | 0.42% | -25.3% |
MRSN | Buy | MERSANA THERAPEUTICS INC | $1,408,000 | +61.5% | 352,763 | +151.5% | 0.37% | +67.6% |
VERO | Sell | VENUS CONCEPT INC | $1,385,000 | -16.5% | 968,187 | -0.8% | 0.36% | -13.4% |
MREO | Buy | MEREO BIOPHARMA GROUP PLCads | $1,363,000 | -24.4% | 1,216,613 | +8.0% | 0.36% | -21.6% |
AERIE PHARMACEUTICALS INCnote 1.500%10/0 | $1,345,000 | +8.2% | 1,500,000 | 0.0% | 0.35% | +11.8% | ||
VKTX | VIKING THERAPEUTICS INC | $1,342,000 | -34.8% | 447,400 | 0.0% | 0.35% | -32.4% | |
ETNB | Buy | 89BIO INC | $1,222,000 | -35.4% | 324,053 | +124.0% | 0.32% | -33.2% |
MEIP | Buy | MEI PHARMA INC | $1,065,000 | -77.4% | 1,767,146 | +0.1% | 0.28% | -76.5% |
GHRS | New | GH RESEARCH PLCordinary shares | $1,006,000 | – | 55,000 | +100.0% | 0.26% | – |
CMPS | New | COMPASS PATHWAYS PLCsponsored ads | $965,000 | – | 74,890 | +100.0% | 0.25% | – |
STIM | NEURONETICS INC | $951,000 | -32.0% | 313,717 | 0.0% | 0.25% | -29.5% | |
Sell | THESEUS PHARMACEUTICALS INC | $924,000 | -25.2% | 80,124 | -17.8% | 0.24% | -22.5% | |
NXTC | NEXTCURE INC | $912,000 | -19.0% | 187,696 | 0.0% | 0.24% | -15.9% | |
BDTX | Buy | BLACK DIAMOND THERAPEUTICS I | $869,000 | -20.9% | 313,600 | +52.2% | 0.23% | -18.1% |
WVE | WAVE LIFE SCIENCES LTD | $780,000 | -36.3% | 390,161 | 0.0% | 0.20% | -34.1% | |
GNFT | Buy | GENFIT S Aads | $752,000 | +149.0% | 187,940 | +210.9% | 0.20% | +157.9% |
ADAP | Buy | ADAPTIMMUNE THERAPEUTICS PLCsponds adr | $723,000 | +41.5% | 351,064 | +157.6% | 0.19% | +46.9% |
New | VIGIL NEUROSCIENCE INC | $701,000 | – | 99,754 | +100.0% | 0.18% | – | |
STRO | Buy | SUTRO BIOPHARMA INC | $696,000 | +3.9% | 84,700 | +88.2% | 0.18% | +7.7% |
PHVS | Sell | PHARVARIS N V | $628,000 | +18.9% | 34,615 | -5.7% | 0.16% | +23.3% |
LVTX | LAVA THERAPEUTICS NV | $613,000 | -20.0% | 139,332 | 0.0% | 0.16% | -17.1% | |
HARP | HARPOON THERAPEUTICS INC | $523,000 | -34.1% | 105,163 | 0.0% | 0.14% | -32.0% | |
PHAS | PHASEBIO PHARMACEUTICALS INC | $500,000 | -49.4% | 378,611 | 0.0% | 0.13% | -47.6% | |
INGN | INOGEN INC | $486,000 | -4.7% | 15,000 | 0.0% | 0.13% | -0.8% | |
SCYX | SCYNEXIS INC | $474,000 | -35.9% | 121,242 | 0.0% | 0.12% | -33.3% | |
MASI | MASIMO CORP | $437,000 | -50.2% | 3,000 | 0.0% | 0.11% | -48.4% | |
CGEN | Sell | COMPUGEN LTDord | $419,000 | -51.6% | 130,202 | -35.4% | 0.11% | -50.0% |
MDGL | Sell | MADRIGAL PHARMACEUTICALS INC | $304,000 | -36.0% | 3,100 | -44.6% | 0.08% | -33.6% |
CMPX | COMPASS THERAPEUTICS INC | $269,000 | -56.8% | 196,091 | 0.0% | 0.07% | -55.1% | |
ASLN | Sell | ASLAN PHARMACEUTICALS LTDads | $219,000 | -73.3% | 243,720 | -66.7% | 0.06% | -72.3% |
LCTX | Buy | LINEAGE CELL THERAPEUTICS IN | $216,000 | +10.2% | 140,000 | +75.0% | 0.06% | +14.3% |
LRMR | Sell | LARIMAR THERAPEUTICS INC | $202,000 | -73.3% | 49,996 | -28.8% | 0.05% | -72.1% |
SRGA | SURGALIGN HOLDINGS INC | $176,000 | -57.6% | 579,710 | 0.0% | 0.05% | -55.8% | |
INFI | Sell | INFINITY PHARMACEUTICALS INC | $137,000 | -74.2% | 120,097 | -49.1% | 0.04% | -73.1% |
ANNX | ANNEXON INC | $84,000 | -76.3% | 30,796 | 0.0% | 0.02% | -75.3% | |
BOLT | Exit | BOLT BIOTHERAPEUTICS INC | $0 | – | -100,000 | -100.0% | -0.12% | – |
PRQR | Exit | PROQR THERAPEUTICS N V | $0 | – | -85,476 | -100.0% | -0.17% | – |
HOOK | Exit | HOOKIPA PHARMA INC | $0 | – | -320,444 | -100.0% | -0.19% | – |
ARNA | Exit | ARENA PHARMACEUTICALS INC | $0 | – | -119,615 | -100.0% | -2.80% | – |
Other managers
Other managers that, in addition to the filing manager(s), that filed the EDGAR filing(s):
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2022-05-16
Top long-term holdings
Name | Quarters owned | Latest quarter owned | Max weighting |
---|---|---|---|
STEREOTAXIS INC | 42 | Q3 2023 | 27.6% |
ATRICURE INC | 42 | Q3 2023 | 11.4% |
MASIMO CORPORATION | 42 | Q3 2023 | 1.8% |
ASCENDIS PHARMA A S SPONSORED | 34 | Q3 2023 | 4.5% |
AERIE PHARMACEUTICALS INC | 33 | Q3 2022 | 4.2% |
GALAPAGOS NV-SPON ADR | 33 | Q3 2023 | 3.8% |
XENON PHARMACEUTICALS INC | 33 | Q3 2023 | 3.6% |
NEUROCRINE BIOSCIENCES INC | 32 | Q3 2023 | 2.9% |
JOHNSON AND JOHNSON | 32 | Q1 2021 | 1.2% |
ISHARES TR NASDQ BIOTECH | 30 | Q3 2023 | 4.0% |
View DAFNA Capital Management LLC's complete holdings history.
Latest significant ownerships (13-D/G)
Filed | Shares | Percentage | |
---|---|---|---|
Stereotaxis, Inc. | March 08, 2018 | 13,680,554 | 23.4% |
SUNESIS PHARMACEUTICALS INC | February 14, 2018 | 983,000 | 2.9% |
SUNESIS PHARMACEUTICALS INC | February 14, 2017 | 1,133,583 | 5.4% |
WINDTREE THERAPEUTICS INC /DE/ | February 14, 2017 | 208,333 | 2.4% |
ANAVEX LIFE SCIENCES CORP.Sold out | February 16, 2016 | 0 | 0.0% |
DISCOVERY LABORATORIES INC /DE/ | February 16, 2016 | 10,658,699 | 9.2% |
PRECISION OPTICS CORPORATION, INC. | February 13, 2015 | 311,537 | 5.0% |
TearLab Corp | February 14, 2013 | 939,239 | 3.2% |
VIKING SYSTEMS INC | February 14, 2012 | 3,781,468 | 5.2% |
View DAFNA Capital Management LLC's complete significant-ownership history.
Latest filings
Type | Filed |
---|---|
13F-HR | 2024-02-14 |
SC 13G/A | 2024-02-14 |
SC 13G | 2024-02-14 |
13F-HR | 2023-11-14 |
13F-HR | 2023-08-14 |
13F-HR | 2023-05-15 |
SC 13G/A | 2023-02-14 |
13F-HR | 2023-02-14 |
13F-HR | 2022-11-14 |
13F-HR | 2022-08-15 |
View DAFNA Capital Management LLC's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.